Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US5886184 | ORGANON | Finasteride processes |
Nov, 2012
(11 years ago) | |
US5547957 | ORGANON | Method of treating androgenic alopecia with 5-α reductase inhibitors |
Oct, 2013
(10 years ago) | |
US5571817 | ORGANON | Methods of treating androgenic alopecia with finasteride [17β-N-mono-substituted-carbamoyl-4-aza-5-α-androst-1-en-ones] |
Nov, 2013
(10 years ago) |
Market Authorisation Date: 19 December, 1997
Treatment: Treating male pattern baldness with 0.05 to 3.0mg/day; Treatment of androgenic alopecia by oral administration drug substance
Dosage: TABLET;ORAL
Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US5886184 | ORGANON | Finasteride processes |
Nov, 2012
(11 years ago) | |
US5942519 | ORGANON | Prevention of precipitated acute urinary retention |
Oct, 2018
(5 years ago) |
Market Authorisation Date: 19 June, 1992
Treatment: Treating precipitated acute urinary retention with finasteride
Dosage: TABLET;ORAL